AMPH R&D Expenses
Amphastar Pharmaceuticals Inc · R&D Expenses
AMPH R&D Expenses
Latest reported$94.57Mperiod ending
AMPH TTM R&D Expenses ($33.02M → $94.57M)
TTM R&D Expenses
High-resolution chart · PNG
AMPH r&d expenses history
Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.
| Period ending | R&D Expenses (USD) |
|---|---|
| 94,569,000 | |
| 92,485,000 | |
| 85,844,000 | |
| 80,672,000 | |
| 79,395,000 | |
| 76,967,000 | |
| 71,104,000 | |
| 73,381,000 | |
| 68,968,000 | |
| 68,159,000 | |
| 73,741,000 | |
| 70,558,000 | |
| 72,408,000 | |
| 78,363,000 | |
| 74,771,000 | |
| 74,821,000 | |
| 67,066,000 | |
| 62,390,000 | |
| 60,932,000 | |
| 61,779,000 | |
| 68,664,000 | |
| 66,691,000 | |
| 67,229,000 | |
| 68,740,000 | |
| 69,702,000 | |
| 69,549,000 | |
| 68,853,000 | |
| 65,943,000 | |
| 58,677,000 | |
| 58,149,000 | |
| 57,802,000 | |
| 52,461,000 | |
| 51,161,000 | |
| 46,425,000 | |
| 43,415,000 | |
| 44,299,000 | |
| 43,982,000 | |
| 43,730,000 | |
| 40,868,000 | |
| 37,245,000 | |
| 38,639,000 | |
| 38,885,000 | |
| 37,065,000 | |
| 36,050,000 | |
| 33,518,000 | |
| 28,786,000 | |
| 28,427,000 | |
| 28,071,000 | |
| 28,527,000 | |
| 30,324,000 | |
| 33,019,000 | |
| 34,474,000 |